HTG Molecular Diagnostics Inc (HTG) is a provider of instruments, reagents, and services for molecular profiling applications. The company's products include HTG edge system, HTG edgeseq reveal software and HTG edgeseq immuno-oncology assay. It develops assays and reagent systems that provide quantitative gene expression analysis in formalin-fixed paraffin embedded tissue. HTG also offers autoimmune panel, immuno-oncology assay, dlbcl cell of origin assay, lung fusions assay, miRNA whole transcriptome assay, mouse mRNA tumor response panel, oncology biomarker panel, and precision immuno-oncology panel. The company serves biopharmaceutical companies, academic research centers and molecular testing laboratories. HTG is headquartered in Tucson, Arizona, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and helps to create effective counter strategies to gain a competitive advantage.
Scope
Reasons to Buy
Note: Some sections may be missing if data is unavailable for the company
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and helps to create effective counter strategies to gain a competitive advantage.
Scope
- The report reviews the detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company HTG Molecular Diagnostics Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides a detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date
Reasons to Buy
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain a competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Table of Contents
HTG Molecular Diagnostics Inc Company Overview
HTG Molecular Diagnostics Inc Pipeline Products Overview
HTG Molecular Diagnostics Inc - Locations and Subsidiaries
Recent Developments
Appendix
List of Tables
HTG Molecular Diagnostics Inc, Key Employees
List of Figures
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Trovagene Srl
- Thermo Fisher Scientific Inc
- Roche Diagnostics Corp
- Personalis Inc
- Personal Genome Diagnostics Inc
- NeoGenomics Inc
- NanoString Technologies Inc
- Luminex Corp
- Illumina Inc
- Guardant Health Inc
- Foundation Medicine Inc
- Fluidigm Corp
- Exact Sciences Corp
- Caris Diagnostics, Inc.
- BioRad Laboratories Inc
- ArcherDx Inc
- Agilent Technologies Inc
- Affymetrix, Inc.
- Abbott Molecular Inc